Gene therapy holds promise for the treatment of many inherited and acquired human diseases. Despite numerous early clinical trials, the effectiveness of human gene transfer and expression remains disappointingly low due to limitations in the current generation of vectors (36) . The ideal vector for human application should permit targeted, highly efficient, long-term gene delivery and be devoid of significant toxicity (26, 36) . Adenovirus vectors have several advantages. Recombinant adenoviruses are easy to manipulate and produce in high titer, can package large quantities of DNA, and have a broad cell tropism. Potent host inflammatory and immune responses, however, limit adenovirus vectors, resulting in transient gene expression and significant morbidity in vivo (17) . Adeno-associated virus (AAV) vectors are increasingly being developed for human gene therapy. AAV vectors demonstrate long-term gene expression in vivo, a broad host range, and the ability to infect growth-arrested cells. In contrast to adenovirus vectors, AAV vectors have not been associated with acute inflammation (7, 8, 17) . Since the use of AAV in human gene therapy protocols is on the rise, it is important to understand the biology of the host response to these vectors.
The acute inflammation induced by adenovirus vectors is due to the activation of target cells and the innate immune system (5, 32) . It was previously demonstrated that adenovirus vectors induce the expression of chemokines following transduction in epithelial cells in vitro (5, 27) . The induction of chemokines in these target cells is direct and occurs independently of virus transcription. In vivo, adenovirus vectors also activate the innate immune system (32, 40) . The innate immune system is comprised of numerous cellular components including neutrophils, natural killer cells, and macrophages that recognize pathogens according to the pattern of their surface components rather than their specific antigenic sequences (14) . An invading pathogen induces a cell to respond rapidly (within minutes to hours) and release an array of inflammatory mediators including cytokines and chemokines (31) . The activation of innate immune responses in vivo also occurs in the absence of virus gene transcription (24, 32) . The activation of target cells and the innate immune system is an important component of host recognition and response to adenovirus vectors (14) .
The direct activation of target cells and the innate immune system by psoralen-inactivated adenovirus vectors suggests a role for the viral capsid in these responses. Thus, the differential induction of acute inflammation in vivo arising from adenovirus and AAV infection is not clear given the similar features of both vectors. Adenoviridae contain a linear double-stranded DNA genome, which is encapsulated in an icosahedral protein shell that is approximately 70 nm in diameter (17) . Adenovirus particles bind to the 46-kDa coxsackievirus adenovirus receptor and are internalized by receptor-mediated endocytosis in clathrin-coated vesicles. ␣ v integrins (␣ v ␤ 1 , ␣ v ␤ 3 , ␣ v ␤ 5 ) are essential for the efficient internalization of adenovirus vectors (21, 28, 38) . The AAV genome is encapsulated as a singlestranded DNA molecule. The nonenveloped virion is also icosahedral in shape but measures only 20 to 25 nm in diameter (7) . Initial attachment of AAV to cells is mediated by interaction with heparan sulfate proteoglycan (34) . Fibroblast growth factor receptor 1 has also been implicated in virus attachment (29) . Using ␣ v ␤ 5 integrins as a coreceptor, AAV vectors gain entry into cells via receptor-mediated endocytosis in a manner similar to that of adenoviruses (2, 33) .
The objective of this study is to determine the effects of AAV vector transduction on the host chemokine induction in vitro and on the activation of innate immune responses in vivo. We demonstrate that adenovirus but not AAV vectors induce chemokine expression in target cells at equivalent titers and transduction efficiencies in vitro. Furthermore, we show for the first time that AAV vectors transiently activate innate immune responses in vivo. These results increase our understanding of viral vector biology and provide a basis for the reduced inflammatory properties exhibited by AAV vectors.
MATERIALS AND METHODS
Virus vectors. The type 5, E1-deleted, E3-defective (pJM17-based) adenovirus expressing Escherichia coli ␤-galactosidase (AdlacZ) under the control of the cytomegalovirus promoter (3, 16) was propagated in 293 cells and purified as previously described (4). After purification, virus was dialyzed against 4 liters of dialysis buffer containing 3% sucrose, 150 mM NaCl, 10 mM Tris (pH 7.4), and 1 mM MgCl 2 for 4 h at 4°C and stored at Ϫ70°C. The control vehicle was made by dialyzing 2-ml aliquots of CsCl (1.34 mg/ml) without virus against the same dialysis buffer as that used for the viral preparations. The adenovirus vector concentration was determined by measuring the optical density at 260 nm as described by Mittereder et al. (25) and was expressed as particles per cell (part/cell). Vectors were screened for replication-competent adenovirus by plaque assay on HeLa cells and PCR and their concentration remained consistently Ͻ1 per 10 10 particles. AAVlacZ vectors were prepared from producer cell lines using wild-type Ad5 as described by Clark et al. (9) and purified by high-pressure liquid chromatography with a POROS HE1/M heparin column. Final vector preparations were dialyzed into buffer as above and stored at Ϫ70°C. The absence of replicationcompetent adenovirus in the AAVlacZ preparations was assayed by passing 1% of the purified vector stock onto 293 cells and scoring for adenovirus cytopathic effect after 7 days. Adenovirus contamination was consistently less than 1 infectious Ad particle per 10 12 AAV particles, when evidenced at all. DNase-resistant particle values were determined using a Perkin-Elmer Applied Biosystems (Foster City, Calif.) Prism 7700 sequence detector as described previously (9) .
Endotoxin testing. Low-endotoxin H 2 O, buffers, and tissue culture reagents were used for vector production and experiments. Adenovirus and AAV vectors were routinely tested for the presence of endotoxin using the Limulus Amebocyte Lysate kit (Bio-Whittaker, Walkersville, Md.). All vectors contained Ͻ0.1 endotoxin units/ml of endotoxin.
Animal studies. Male DBA/2 (H-2 d ) mice were obtained from Charles River Laboratories (Wilmington, Mass.) and housed under standard conditions. All animals were used at 10 to 12 weeks of age (25 to 30 g). Under methoxyfluorane general anesthesia, 2.5 ϫ 10 9 to 2.5 ϫ 10 11 particles of AdlacZ or AAVlacZ was injected via the femoral vein in a total volume of 100 l (vector plus sucrose vehicle). Control animals were treated with 100 l of sucrose vehicle alone (3% sucrose, 150 mM NaCl, 10 mM Tris [pH 7.4], 1 mM MgCl 2 ). Animals were allowed to recover and then were sacrificed at predetermined time points, and the livers and sera were harvested for analysis. For Kupffer cell depletion experiments, gadolinium chloride (GdCl 3 ) (10 mg/kg of body weight in a total volume of 100 l) was injected via the tail vein 48 and 24 h prior to viral vector administration. All animal studies were performed in accordance with the Animal Care Committee guidelines at the University of Calgary.
Cell culture. The immortalized, nontransformed, epithelium-derived DBA/2 mouse kidney cell line (renal epithelium-derived cells [REC cells]) (5, 39) and human HeLa cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1% penicillin-streptomycin (GIBCO-BRL, Rockville, Md.). Viral transductions were performed in six-well plates with 10 6 cells/well. Cells were incubated with 1 ml of medium per well containing viral vectors followed by incubation at 37°C in 5% CO 2 for 1 or 6 h for RNase protection assays. Depending on the experiment, cells were harvested with trypsin or by direct lysis.
RNase protection assays. Liver tissues and cells were processed for total RNA using RNeasy (Qiagen, Chatsworth, Calif.) according to the manufacturer's protocol. RNase protection assays were performed using the RiboQuant MultiProbe RNase protection assay system (PharMingen, San Diego, Calif.). Briefly, by using the multiprobe template set mCK5-mCK3 for mouse cells or hCK5 for human cells, a [
32 P]UTP-labeled RNA probe was transcribed using T7 polymerase followed by phenol-chloroform extraction and ethanol precipitation. The concentration of the probe was adjusted to 3 ϫ 10 5 cpm/l (mCK3 and mCK5) or 3.1 ϫ 10 5 (hCK5) cpm/l. Seven micrograms of RNA per sample was hybridized to 6 ϫ 10 5 cpm of total probe overnight at 56°C. Samples were then digested with RNase, followed by proteinase K treatment and phenol-chloroform extraction. After ethanol precipitation with 4 M ammonium acetate, protected samples were resuspended in 1ϫ loading buffer and separated on 5.7% acrylamidebisacrylamide urea gels. After drying, the gels were visualized by autoradiography.
Slot and Southern blot analysis. To obtain total cell DNA, transduced cells were trypsinized for 5 min and washed several times with phosphate-buffered saline (PBS) to remove bound virus from the cell surface. The pellet was lysed in 300 l of lysis buffer (100 mM NaCl, 10 mM Tris [pH 8.0], 25 mM EDTA [pH 8.0], 0.5% sodium dodecyl sulfate [SDS], 0.1 mg of proteinase K per ml) and incubated at 50°C for 2 h. Liver samples were lysed in 500 l of the same buffer and incubated at 50°C overnight. Nucleic acids were thoroughly extracted with phenol-chloroform-isoamyl alcohol (25:24:1), and the aqueous layer was ethanol precipitated. The DNA was resuspended in double-distilled water. For Southern analysis, 3 g of total DNA was digested with HindIII and separated on a 1% agarose gel. The gel was washed in 0.25 M HCl followed by another wash in a 0.4 M NaOH solution, and the DNA alkaline was transferred onto a Hybond XL nylon membrane (Amersham Pharmacia). A 3,121-bp fragment spanning the entire lacZ gene was labeled with [ 32 P]dCTP with the Redprime random prime labeling system (Amersham Pharmacia) and served as probe. Hybridizations were performed by using 2 ng of labeled probe per ml in 5 ml of ExpressHyb solution (Clontech, Palo Alto, Calif.) at 60°C for 1 h. The membrane was then washed in 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS for 30 min and twice in 0.2ϫ SSC-0.1% SDS for 30 min at 50°C and exposed to radiographic film. For slot blot analysis 1 g of total DNA from tissue culture cells or 2 g of total DNA from liver samples was diluted with NaOH and EDTA to a final concentration of 0.4 M NaOH and 10 mM EDTA, heat denatured, and fixed onto a positively charged Hybond XL nylon membrane (Amersham Pharmacia) using a slot blot manifold. The membrane was subsequently rinsed with 0.4 M NaOH and hybridized as described above.
Histology and liver function tests. Mice were sacrificed, and livers were harvested, rinsed in PBS, and fixed in 10% formalin. A portion of the liver was also snap-frozen in O.C.T. compound (Tissue Tek) and stored at Ϫ70°. Formalinfixed tissues were embedded in paraffin. Five-micrometer-thick sections were stained with eosin and hematoxylin (for neutrophils, with chloroacetate esterase staining [Leder stain]) and analyzed by light microscopy in a blinded fashion.
Immunohistochemistry was performed by fixing 5-m-thick frozen tissue sections for 10 min in acetone at 4°C followed by three washes in cold PBS for 10 min each. Sections for F4/80 staining to detect Kupffer cells were quenched in 0.3% H 2 O 2 in PBS for 10 min. Sections were then blocked with rabbit serum for 30 min and avidin-biotin for 10 min (Vector Laboratories, Burlingame, Calif.) and were then incubated with a 1:500 dilution of rat anti-mouse CD11b (Mac-1) antibody (BD Pharmingen) or 1:100 dilution of the Kupffer cell-specific F4/80 (Serotec) for 1 h at room temperature. After being washed with PBS, sections were incubated with rabbit anti-rat immunoglobulin G (IgG) antibody for 30 min at room temperature and then stained using the ABC protocol and DAB substrate (Vector Laboratories). Leukocyte numbers were determined by counting the number of positive-stained cells over 40 fields at a magnification of ϫ40. The mean number of positive cells per high power field (hpf) was then calculated.
Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/ GPT) determinations were performed on mouse serum using the Sigma Diag- 3 part/cell failed to increase chemokine expression compared to vehicle-treated cells (Fig. 1A) . The titer (200 ϫ 10 3 part/cell) of AAV is 40-fold greater than that of the lowest concentration of adenovirus required to induce chemokine expression. In HeLa cells, AdlacZ efficiently induced the expression of RANTES and interleukin-8 (IL-8) in a dose-dependent manner. IP-10 and MIP-1␣ mRNAs were also increased following transduction with AdlacZ but to a much lower extent. As in REC cells, AAVlacZ failed to increase expression of these chemokines above baseline despite transduction with higher titers (Fig. 1B) . Chemokine induction was not detected in REC or HeLa cells 1 h following transduction with either AAVlacZ or AdlacZ (data not shown).
One potential explanation for the differential chemokine induction by AdlacZ and AAVlacZ may be from differences in cell transduction. To examine this possibility, we compared the transductions of HeLa cells and REC cells by AdlacZ and AAVlacZ from total DNA harvested 6 h following transduction. Vector genomes in total DNA were probed for the LacZ transgene in slot blot analyses. To ensure that equivalent amounts of total cell DNA were loaded in each slot, the blot was also hybridized with the housekeeping gene control glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Results ( Fig. 2A) showed that the signal corresponding to AdlacZ vector DNA increased with increasing titers in both REC and HeLa cells. Total DNA from AAVlacZ-transduced REC and HeLa cells demonstrated a very strong lacZ signal corresponding with the high titers used (2 ϫ 10 11 to 4 ϫ 10 11 part/cell) ( Fig. 2A) . These findings confirmed that vector genomes in AAVlacZ-and AdlacZ-transduced REC and HeLa cells correlated with the infecting particle number.
Following cell entry, single-stranded AAV vector genomes slowly convert to double-stranded forms and concatemers. This process results in various intermediate forms during early infection (11, 23) . Thus, to confirm that AAVlacZ genomes were intracellular as opposed to due to background contamination from cell surface-bound virus, we analyzed the DNA samples using Southern blot analyses. Probing for the lacZ transgene in HindIII-digested total DNA, a single 7,500-bp fragment was detected in AdlacZ-transduced REC and HeLa cells. The abundance of this band correlated with increasing titers of adenovirus vector used to transduce the cells (Fig. 2B) . In contrast to the low-molecular-weight appearance of uninternalized AAV genomes (19) , large-molecular-weight AAV vector genomes of various sizes were detected in AAVlacZtransduced cells, characteristic of the early stages of AAV infection (11, 12, 23) . Together these results demonstrate that in contrast to AdlacZ, AAVlacZ effectively transduces epithelium-derived target cells without inducing the expression of chemokines. AAV vectors induce the expression of chemokines and cytokines in vivo. The preceding studies were performed in cell culture and provided the basis for studies in whole animals. To determine the host response to AAV vectors in vivo, hepatic chemokine and cytokine mRNA levels were examined in DBA/2 mice following administration of adenovirus or AAV vectors. DBA/2 mice were injected intravenously with 2.5 ϫ 10 9 , 2.5 ϫ 10 10 , or 2.5 ϫ 10 11 particles of AdlacZ or AAVlacZ. Animals were sacrificed at 1, 6, and 24 h following injection of virus. Both livers and sera were collected for analysis.
As previously reported, AdlacZ induced the expression of many inflammatory chemokines in the liver as determined by RNase protection assay (27) . Results (Fig. 3A) showed that MIP-1␤, MIP-2, MCP-1, and IP-10 mRNAs were induced in a dose-dependent manner as early as 1 h following the administration of AdlacZ. Furthermore, chemokine mRNA levels increased from 1 to 6 h and remained elevated for the duration of the experiment that was terminated at 24 h (Fig. 3A) . Surprisingly, AAVlacZ also induced the expression of chemokine mRNAs in vivo. One hour following the intravenous administration of 2.5 ϫ 10 11 particles of AAVlacZ, RANTES, MIP-1␤, MIP-2, MCP-1, and IP-10 mRNA levels were significantly upregulated. In contrast to what was observed with AdlacZ, however, chemokine mRNA expression was not induced following transduction with lower titers (2.5 ϫ 10 9 and 2.5 ϫ 10 10 particles of AAVlacZ), suggesting a higher and more distinct threshold for AAVlacZ-induced chemokine expression in vivo. Interestingly, AAVlacZ-induced chemokine mRNA expression was transient and returned to undetectable levels within 6 h. Similar patterns of induction (Fig. 3B) were seen with the cytokines lymphotoxin ␤ (LTB-␤) and tumor necrosis factor alpha (TNF-␣). At 6 h postinjection 2.5 ϫ 10 11 particles of AdlacZ induced the expression of TNF-␣ and LTB-␤ mRNAs with the highest level of induction. The same titer of AAVlacZ up-regulated TNF-␣ and LTB-␤ mRNAs at 1 h following vector administration but returned to baseline before 6 h (Fig.  3B) . Transcripts for IL-6, IL-1␤, and gamma interferon (data not shown) were not detectable at any time following the administration of AAVlacZ. These results show that AAV vectors induce the expression of chemokines and cytokines in vivo but that the response is transient and occurs at a higher threshold titer than that for adenovirus vectors.
To confirm that both AAVlacZ and AdlacZ transductions of liver were equivalent, total liver DNA was analyzed using (Fig. 4A) . Furthermore, Southern blot analysis confirmed the variable sizes of AAV vector genomes typical of its intracellular location (Fig. 4B) . These data confirm that differential inductions of chemokine and cytokine expression arising from adenovirus and AAV vectors are not due to differences in transduction efficiency.
AAV vectors induce transient hepatic leukocyte infiltration in vivo.
To determine whether AAV vector induction of chemokines and cytokines in the liver was associated with the recruitment of leukocytes and/or toxicity, livers of vector-injected animals were analyzed histologically. The intravenous administration of 2.5 ϫ 10 11 particles of AdlacZ increased both neutrophil (Fig. 5A ) and CD11b ϩ (Fig. 5B ) cell (neutrophils, natural killer cells, monocytes) recruitment to the liver over 1 h. Quantifying (Fig. 5C and D) the number of cells 1 h (Fig. 5D ). In contrast, the same titer of AAVlacZ only transiently induced leukocyte recruitment to the liver (Fig. 5A and B) . At 1 h postinjection, AAVlacZ-transduced livers contained 7.5 Ϯ 1.1 CD11b ϩ cells/hpf and 4.0 Ϯ 2.0 neutrophils/hpf, similar to the leukocyte recruitment induced by AdlacZ. At 6 h following transduction, the number of infiltrating leukocytes had returned to baseline, similar to that of vehicle-treated animals ( Fig. 5C and D) . Morphologically, the administration of 2.5 ϫ 10 11 particles of AdlacZ induced extensive hepatic necrosis at 24 h as determined by hematoxylin and eosin staining. In contrast, the livers of animals that received vehicle or 2.5 ϫ 10 11 particles of AAVlacZ were histologically normal at 24 h (Fig.  6A) . The lack of liver toxicity arising from the administration of AAVlacZ was consistent with reduced serum liver transaminase levels measured 24 h following vector administration (aspartate aminotransferase levels were 81 Ϯ 28 SF units/ml for vehicle versus 221 Ϯ 48 SF units/ml for AdlacZ versus 124 Ϯ 4 SF units/ml for AAVlacZ [n ϭ 3]; alanine aminotransferase levels were 31 Ϯ 10 SF units/ml for vehicle versus 199 Ϯ 27 SF units/ml for AdlacZ versus 26 Ϯ 2 SF units/ml for AAVlacZ [n ϭ 3]) (Fig. 6B) . These results show that although AAV vectors induce leukocyte recruitment following liver transduction in vivo, it is transient and not associated with significant liver inflammation or toxicity. In contrast, adenovirus vectors are associated with a prominent and persistent host inflammatory response.
AAV vector-induced chemokine expression and leukocyte recruitment are Kupffer cell dependent. The source of chemokine and cytokine expression following the administration of AAV and adenovirus vectors may originate from transduced hepatocytes, Kupffer cells, or infiltrating inflammatory cells. Kupffer cells have been shown to play an instrumental role in the innate immune response to adenovirus vectors (22, 40) . Therefore, we tested the abilities of both viral vectors to induce chemokine and cytokine expression and to recruit leukocytes in the absence of Kupffer cells. DBA/2 mice were depleted of Kupffer cells by using a modified GdCl 3 protocol (15). Mice were injected intravenously with GdCl 3 (10 mg/kg) 48 and 24 h prior to the intravenous administration of vehicle or 2.5 ϫ 10 11 particles of AdlacZ or AAVlacZ. At 24 h following the last injection of GdCl 3, liver Kupffer populations were reduced by Ͼ90%. This value was determined by using the Kupffer cellspecific antibody F4/80 in immunohistochemical analysis of the samples (Fig. 7A) . Blinded quantification of liver Kupffer cells revealed 0.9 Ϯ 1 F4/80-positive cells/hpf (ϫ40) in GdCl 3 -treated animals compared to 98 Ϯ 22 F4/80-positive cells/hpf in normal animals. In vehicle-treated animals, liver chemokine and cytokine mRNA expression was not increased over baseline at 1, 6, and 24 h as determined by RNase protection assay. This finding confirmed that GdCl 3 did not affect basal gene expression in the liver. Kupffer cell depletion did not affect AdlacZ-induced chemokine mRNA expression in the liver at 1 h following intravenous administration (Fig. 7B) . In contrast, the induction of chemokines following intravenous administra- tion of AAVlacZ was completely abolished in Kupffer celldepleted animals at 1 h (Fig. 7B) . Additionally, the expression of LTB-␤ and TNF-␣ mRNA was absent following AAVlacZ but not AdlacZ administration in Kupffer cell-depleted animals (Fig. 7C) . Consistent with these results, Kupffer cell depletion also reduced AAVlacZ-induced hepatic leukocyte recruitment at 1 h to baseline (Fig. 5) . Adenovirus vectorinduced leukocyte recruitment to the liver was only slightly reduced in Kupffer cell-depleted animals. These results show that AAV but not adenovirus vector-induced chemokine and cytokine expression and leukocyte recruitment in the liver are dependent solely on Kupffer cells.
To determine whether the reduction in chemokine and cytokine expression following Kupffer cell depletion in AAVlacZinfected mice was due to decreased liver transduction, viral genomes were assessed by slot and Southern blot analysis of total liver DNA. Probing for the LacZ transgene, slot blot analysis revealed similar amounts of AAVlacZ and AdlacZ genomes in the livers of Kupffer cell-depleted animals at 1 h (Fig. 8A) . Southern blot analysis of total liver DNA again revealed multiple species of AAV genomes, confirming its intracellular location (Fig. 8B) . These data confirm that Kupffer cell depletion does not substantially reduce the transduction of liver by AAVlacZ.
DISCUSSION
The relative lack of inflammatory responses in AAV-transduced hosts compared to the acute toxicity and inflammation induced by adenovirus vectors prompted us to embark on the studies in this report (17) . Although these observations have been documented in numerous studies in vivo (13, 18, 37) , the potential molecular mechanism(s) underlying these divergent responses is not clear. The results of our studies in vitro showed that adenovirus but not AAV vectors induced the expressions of various chemokines in two epithelium-derived cell lines, REC and HeLa. The differential induction of chemokines was evident in vitro despite exposure of cells to AAV titers that were 40-fold higher than the lowest titer of adenovirus required to initiate the response. Since cells cultured in vitro do not reflect the response in the whole animal, mice were used to examine whether findings in culture extended to an in vivo model. We found that AAV vectors in vivo induced only transient chemokine and cytokine expression and leukocyte recruitment in the liver. This response was not associated with significant toxicity or inflammation. In contrast, the chemokine and cytokine induction following exposure of mice to adenovirus vectors was rapid, marked, and sustained. These features stand in direct contrast to what is observed with AAV and confirm the differences in host responses to these two vectors.
The early host response to viral infection involves interaction between two components, the infected target cell and the innate immune system (14) . We and others have previously demonstrated with epithelium-derived target cells in vitro that adenovirus vectors induce the expression of chemokines (1, 5, 27) . The molecular basis for adenovirus vector induction of host inflammatory genes has been studied in nonmacrophage target cells. For example, adenovirus transduction of HeLa cells activates Raf-1 and the extracellular signal-regulated kinase signaling pathway. These events trigger expression of the C-X-C chemokine IL-8 (6) . It was previously shown in epithelium-derived REC cells that the nuclear translocation of NF-B is an important component of adenovirus vector induction of the C-X-C chemokine IP-10 (5). These findings illustrate the ability of adenovirus vectors to induce the expression of host inflammatory genes.
Unlike the situation with adenovirus vectors, the impact of AAV vector transduction in target cells has not been extensively studied. Recently, Stilwell and Samulski reported the effects of AAV-2 and adenovirus vectors on cellular gene expression in lung fibroblasts in studies using DNA microarray technology adenovirus, AAV vectors may lack a feature or features that enable them to activate signal transduction pathways following viral cell entry. It is possible that differences in surface receptor usage, virus internalization, or intracellular trafficking may result in differential activation of signaling pathways by these two vectors. For example, there is evidence suggesting that AAV particles enter the nucleus prior to uncoating and this pathway differs from the entry of adenovirus particles (2) . Furthermore, AAV virions may need to be routed as far as the late endosome before penetration into the cytosol. This route contrasts with the early endosome escape during adenovirus infection (10) . The inability of AAV vectors to induce the expression of host genes in target cells may underlie the truncated inflammatory response induced by these agents in vivo. The target cell response acts in collaboration with the innate immune system in the early host response to invading pathogens, including viruses (14) . Effector cells of the innate immune system include macrophages, neutrophils, and natural killer cells that serve as the primary defense to infection. Adenovirus vectors efficiently activate the innate immune system, a response that leads to acute inflammation of transduced tissues and reduced gene transfer efficiency (22, 32, 35, 41) . Resident macrophages such as Kupffer cells in the liver and alveolar macrophages in the lung are significant components of the innate immune system that mediate the acute inflammatory response to adenovirus vectors (32, 35, 41) . In addition to performing important phagocytic and antigen presenting functions, macrophages secrete cytokines and chemokines in response to viral infection, which in turn trigger multiple effects (22, 40) . These effects include leukocyte recruitment to infected tissues and the participation of other effector cells of the immune system, resulting in a cascade of events that propagate the inflammatory response (30) . The results of our studies in vivo show a Kupffer cell-dependent activation of innate immune responses following AAV vector administration. While this outcome is unexpected, it is not surprising given the role of Kupffer cells in the first line of defense against invading pathogens in the liver (20) . Although AAV vectors induced transient chemokine and cytokine expression and leukocyte recruitment to the liver, this response did not result in detectable tissue damage or inflammation. In contrast, the induction of chemokines and cytokines by adenovirus vectors was greater in magnitude, prolonged, and associated with widespread liver inflammation. These findings suggest that a sustained increase in chemokine and cytokine expression appears to be required to trigger more-severe inflammation in the liver.
The AdlacZ in the absence of Kupffer cells is consistent with our in vitro data demonstrating a lack of chemokine induction by AAV vectors in nonmacrophage target cells. While macrophages may simply be more sensitive than epithelial cells to AAV transduction, these results raise the possibility that AAV vectors interact with macrophage and nonmacrophage cells via different mechanisms. The induction of chemokines and cytokines by AAV vectors in vivo is likely not due to viral gene or transgene expression. Recombinant AAV vectors lack wild-type viral genes, and furthermore, lacZ expression in AAVlacZ-transduced livers was not detectable within 24 h (data not shown). The differential activation of chemokines and cytokines by adenovirus and AAV vectors is also not likely the result of adenovirus gene expression. Transcription-defective adenovirus particles have been shown to induce chemokine and cytokine expression in vitro and induce acute inflammation in vivo (5, 24, 27, 32) .
Viral vector-induced immunity and toxicity limit the success of human gene therapy. Our results demonstrate, for the first time, the involvement of the innate immune system in the host response to AAV vectors. While AAV vectors transiently activate cells of the innate immune system, they have a limited capacity to trigger the expression of proinflammatory genes and induce inflammation in transduced tissues. The impact of the innate immune system on AAV-mediated gene transfer remains to be determined. Since the innate immune system significantly reduces adenovirus gene transfer efficiency (35) , the activation of innate immune responses may also affect AAV-mediated gene delivery. Understanding the molecular mechanism underlying the differential activation of innate immune responses between adenovirus and AAV vectors is expected to facilitate the design of safer, more-effective vectors for human gene therapy. 
